TAF9B
protein-codingTATA-box binding protein associated factor 9b
Gene summary
Initiation of transcription by RNA polymerase II requires the activities of more than 70 polypeptides. The protein that coordinates these activities is transcription factor IID (TFIID), which binds to the core promoter to position the polymerase properly, serves as the scaffold for assembly of the remainder of the transcription complex, and acts as a channel for regulatory signals. TFIID is composed of the TATA-binding protein (TBP) and a group of evolutionarily conserved proteins known as TBP-associated factors or TAFs. TAFs may participate in basal transcription, serve as coactivators, function in promoter recognition or modify general transcription factors (GTFs) to facilitate complex assembly and transcription initiation. This gene encodes a protein that is similar to one of the small subunits of TFIID, TBP-associated factor 9, and is also a subunit of TFIID. TAF9 and TAF9b share some functions but also have distinct roles in the transcriptional regulatory process. [provided by RefSeq, Jul 2008]
- TAF9L
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~9.9 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
No GenCC data available for this gene.
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to TAF9B variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_015975.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 2 | 4 | |||
| missense | 30 | 30 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 1 | 1 | ||||
| Total | 0 | 0 | 33 | 2 | 0 | 35 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_057059.2 | 7 | MANE Select | |
| Ensembl | ENSP00000339917.5 | 7 | MANE Select | |
| Ensembl | ENSP00000558717.1 | 6 | Standard | |
| Ensembl | ENSP00000558717.1 | 6 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Basal transcription factors - Homo sapiens (human)
- Herpes simplex infection - Homo sapiens (human)
- miR-targeted genes in lymphocytes - TarBase
- Disease
- Gene expression (Transcription)
Biological Process
- negative regulation of transcription by RNA polymerase II
- transcription by RNA polymerase II
- transcription initiation from RNA polymerase II promoter
- protein deubiquitination
- positive regulation of cell growth
Molecular Function
- transcription corepressor activity
- histone acetyltransferase activity
- protein binding
- transcription factor binding
- thiol-dependent ubiquitinyl hydrolase activity
Cellular Component
- SAGA complex
- nucleoplasm
- transcription factor TFIID complex
- transcription factor TFTC complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000341864
- Coding exons
- 7
- Length
- 9959
- Individuals with no LoFs
- 125698
- Homozygous LoFs
- 13
- Heterozygous LoFs
- 34
- Defined
- 125745
- p
- 0.000187
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.113 | 98 | 94.9 | 1.03 | 0.00000676 | 1636 |
| Missense (PolyPhen) | 29 | 18.155 | 1.5974 | 327 | ||
| Synonymous | -1.61 | 48 | 35.7 | 1.34 | 0.00000276 | 501 |
| Loss of Function | -1.20 | 13 | 9.08 | 1.43 | 7.42e-7 | 148 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00062 | 0.00049 | rare |
| Latino/Admixed American | 0.00012 | 0.000087 | rare |
| Ashkenazi Jewish | 0.00013 | 0.000099 | rare |
| East Asian | 0.00044 | 0.00033 | rare |
| Finnish | 0.00012 | 0.000092 | rare |
| European (Non-Finnish) | 0.00022 | 0.00016 | rare |
| South Asian | 0.00037 | 0.00023 | rare |
| Other | 0.00047 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Essential for cell viability. TAF9 and TAF9B are involved in transcriptional activation as well as repression of distinct but overlapping sets of genes. May have a role in gene regulation associated with apoptosis. TAFs are components of the transcription factor IID (TFIID) complex, the TBP-free TAFII complex (TFTC), the PCAF histone acetylase complex and the STAGA transcription coactivator-HAT complex. TFIID or TFTC are essential for the regulation of RNA polymerase II-mediated transcription. {ECO:0000269|PubMed:15899866}.;
Recessive Scores
- pRec
- 0.120
Intolerance Scores
- LoFtool
- 0.751
- RVIS EVS
- -0.25
- RVIS percentile EVS
- 35.42
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.964
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |